|
David Summa, President and CEO, spoke with Wall Street Reporter Magazine on January 25, 2007
January 25, 2007
ACUMEN PHARMACEUTICALS INC. ANNOUNCES MILESTONE ACHIEVEMENT IN COLLABORATION WITH MERCK & CO., INC.
January 22, 2007
Acumen Pharmaceuticals Names Dr. William F. Goure Chief Operating Officer
November 6, 2006
Acumen Joins Neurotechnology industry Organization
Oct 23, 2006
Coverage in Genetic Engineering News from The Neurotech Industry Conference in May 2006
May 2006
Acumen Press Briefing at 2006 ICAD
July 20, 2006
The Executive Interview with Wall Street Reporter
March 22, 2006
The National Institute on Aging Awards Acumen Pharmaceuticals’ Alzheimer’s Work
Sept 15, 2005
Acumen Pharmaceuticals Receives SBIR Award From National Institute on Aging
August 11, 2005
Acumen and Merck Enter Into Alzheimer's Collaboration
January 13, 2004
The Executive Interview with The Wall Street Transcript
April 23, 2003
Acumen Closes First Round of Financing; Dr. Mark Cochran Joins Board
March 13, 2003
Dave Summa Joins Acumen as President and CEO
March 12, 2003
Solving the Riddle of Amyloid and Alzheimer's Disease
Newsletter by NWU Alzheimer Center [full article in pdf]
New Hypothesis Aims To Upend Received Wisdom Anent Fibrils, Plaques, Tangles Of Alzheimer’s
May 5, 2001 on Bioworld Online [full article in pdf]
|
